Northern Trust’s IGC Pharma IGC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.7K | Hold |
113,407
| – | – | ﹤0.01% | 4289 |
|
|
2025
Q1 | $32.3K | Hold |
113,407
| – | – | ﹤0.01% | 4290 |
|
|
2024
Q4 | $38.1K | Buy |
113,407
+42,380
| +60% | +$14.2K | ﹤0.01% | 4298 |
|
|
2024
Q3 | $30.3K | Hold |
71,027
| – | – | ﹤0.01% | 4283 |
|
|
2024
Q2 | $30.8K | Sell |
71,027
-337
| -0.5% | -$146 | ﹤0.01% | 4282 |
|
|
2024
Q1 | $28.5K | Hold |
71,364
| – | – | ﹤0.01% | 4299 |
|
|
2023
Q4 | $20K | Hold |
71,364
| – | – | ﹤0.01% | 4365 |
|
|
2023
Q3 | $25.6K | Hold |
71,364
| – | – | ﹤0.01% | 4286 |
|
|
2023
Q2 | $22.2K | Hold |
71,364
| – | – | ﹤0.01% | 4389 |
|
|
2023
Q1 | $24.2K | Buy |
71,364
+8,036
| +13% | +$2.73K | ﹤0.01% | 4412 |
|
|
2022
Q4 | $20.1K | Hold |
63,328
| – | – | ﹤0.01% | 4486 |
|
|
2022
Q3 | $27K | Hold |
63,328
| – | – | ﹤0.01% | 4485 |
|
|
2022
Q2 | $34K | Hold |
63,328
| – | – | ﹤0.01% | 4524 |
|
|
2022
Q1 | $60K | Hold |
63,328
| – | – | ﹤0.01% | 4494 |
|
|
2021
Q4 | $62K | Hold |
63,328
| – | – | ﹤0.01% | 4553 |
|
|
2021
Q3 | $94K | Hold |
63,328
| – | – | ﹤0.01% | 4417 |
|
|
2021
Q2 | $104K | Hold |
63,328
| – | – | ﹤0.01% | 4355 |
|
|
2021
Q1 | $113K | Buy |
63,328
+337
| +0.5% | +$601 | ﹤0.01% | 4258 |
|
|
2020
Q4 | $98K | Sell |
62,991
-21,542
| -25% | -$33.5K | ﹤0.01% | 4117 |
|
|
2020
Q3 | $88K | Sell |
84,533
-5,523
| -6% | -$5.75K | ﹤0.01% | 3990 |
|
|
2020
Q2 | $54K | Sell |
90,056
-3,541
| -4% | -$2.12K | ﹤0.01% | 4047 |
|
|
2020
Q1 | $46K | Hold |
93,597
| – | – | ﹤0.01% | 3967 |
|
|
2019
Q4 | $59K | Hold |
93,597
| – | – | ﹤0.01% | 4027 |
|
|
2019
Q3 | $91K | Buy |
93,597
+52,318
| +127% | +$50.9K | ﹤0.01% | 3938 |
|
|
2019
Q2 | $68K | Buy |
+41,279
| New | +$68K | ﹤0.01% | 4030 |
|